Search For "clinical trials"
Optimus Pharma gets DCGI nod for conducting Phase III Clinical Trials for
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], May 25 (ANI/PRNewswire): Optimus Pharma on the 19th of May 2021 received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild to Moderate Covid-19 patients.
Read More
Mexico to conduct clinical trials of Walvax, Sanofi Vaccines: Foreign Secr
Updated : 4 years, 9 months ago IST
Mexico City [Mexico], May 25 (ANI/Sputnik): Mexico intends to conduct clinical trials of vaccines against COVID-19 developed by China's Walvax and France's Sanofi, Foreign Secretary Marcelo Ebrard said.
Read More
Drugs manufacturer from Hyderabad on overdrive
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], May 19 (ANI/PNN): Optimus Pharma on Tuesday received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild and Moderate Covid-19 symptoms.
Read More
Delhi HC refuses to put stay on Phase 2-3 clinical trials of Covaxin for 2
Updated : 4 years, 9 months ago IST
New Delhi [India], May 19 (ANI): The Delhi High Court on Wednesday refused to put an interim stay on Phase 2-3 clinical trials of Covaxin COVID-19 vaccine for the 2-18 age group.
Read More
Quash notification allowing phase 2/3 trials of Covaxin in 2-18 years age
Updated : 4 years, 10 months ago IST
New Delhi [India], May 18 (ANI): A Public Interest Litigation (PIL) has been moved in Delhi High Court seeking quashing of Centre's "notification" of May 13, which has accorded permission for conduct of phase two/three clinical trials of Covaxin in the age group 2 to 18 years to its manuf
Read More
Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12
Updated : 4 years, 10 months ago IST
New Delhi [India], May 18 (ANI): Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday.
Read More
Cardiologist leads commission to help reduce burden of women's heart disea
Updated : 4 years, 10 months ago IST
New York [US], May 17 (ANI): A unique commission that issued major new recommendations aimed at fully understanding and reducing the global burden of heart disease in women was led by Roxana Mehran, MD, Professor of Medicine, and Population Health Science and Policy, and Director of Interven
Read More
Plea in SC seeks disclosure of clinical trials data for COVID-19 vaccines
Updated : 4 years, 10 months ago IST
New Delhi [India], May 14 (ANI): A plea has been filed in the Supreme Court seeking transparency in Covid-19 vaccine clinical trial and post-vaccination data, including the recording and reporting of adverse events.
Read More
DCGI approves Phase 2, 3 clinical trials of COVAXIN on children aged 2 to
Updated : 4 years, 10 months ago IST
New Delhi [India], May 13 (ANI): The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare.
Read More
European Medicines Agency experts beginning Sputnik V manufacturing inspec
Updated : 4 years, 10 months ago IST
Moscow [Russia], May 12 (ANI/Sputnik): Experts from the European Medicines Agency (EMA) are beginning Russia's Sputnik V COVID-19 vaccine manufacturing inspections, as they have already completed the study of clinical trials, the results of both sets of the inspections will be integrated int
Read More
Subject Expert Committee gives nod to Covaxin for Phase 2, 3 trials on chi
Updated : 4 years, 10 months ago IST
New Delhi [India], May 12 (ANI): The Subject Expert Committee (SEC) has given a nod to Bharat Biotech's Covaxin for Phase 2 and 3 human clinical trials on children aged between two to eight years old, sources confirmed on Wednesday.
Read More
Switch of breast tumors to HER2-low might provide greater therapeutic opti
Updated : 4 years, 10 months ago IST
Lugano [Switzerland], May 9 (ANI): The finding that breast tumours can evolve to express low HER2 potentially widens the number of patients who can benefit from new investigational agents, typically novel antibody-drug conjugate therapies, that are currently in clinical trials for HER2-low t
Read More